Gilead Sciences, Inc.'s Viread Reduces HIV Risk for Drug Users in Study

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Gilead Sciences Inc. 's Viread pill reduced the risk of injected-drug users contracting the AIDS virus by half in a study in Thailand, a finding that may give public health officials a new weapon to fight HIV's spread.

http://www.biospace.com/news_story.aspx?StoryID=299907&full=1